InnSuites Hospitality (AMEX:IHT) Stock, Quote.Headers.trade-ideas

InnSuites Hospitality

InnSuites Hospitality Trust is a real estate investment trust. It is engaged in the ownership and operation of hotel properties. It owns and operates hotels, provides management services for hotels, and also provides trademark license services. The Trust is also involved in various operations incidental to the operation of hotels, such as the operation of restaurants, meeting/banquet room rentals, and the operation of a reservation system. It has one reportable segment Hotel Operations & Hotel Management Services.

real estate 1

News

Short Ideas

Pre-Market Outlook

Markets

Trading Ideas

Top 4 Real Estate Stocks That May Plunge This Month

Penny Stocks

Small Cap

Intraday Update

Movers

ACNT

ARBB

ASST

BAOS

BCLI

BETS

BJDX

CHRS

CING

COIN

CYTK

ELTX

EWTX

FWBI

GDHG

HALL

Inspira Technologies Oxy BHN Ltd Ordinary Shares

IINN

IOVA

JTAI

JZXN

LIDR

MGAM

MOBX

MTNB

MYND

NUKK

ONCT

ORGO

RPHM

SMFL

VLCN

VNCE

VRAX

WULF

Shares of  Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM) shares rose sharply during Wednesday’s session after Concentra sent an acquisition proposal to acquire 100% of equity of the company for $1.80 per share.

Reneo Pharmaceuticals shares climbed 13.6% to $1.59 on Wednesday.

Why Reneo Pharmaceuticals Shares Are Trading Higher By Around 14%? Here Are Other Stocks Moving In Wednesday&#39;s Mid-Day Session

LNZA

NTES

SKIN

U.S. stocks traded mostly higher, with the Dow Jones index gaining around 80 points on Wednesday.

Iovance Biotherapeutics, Nio, NetEase And Other Big Stocks Moving Lower On Wednesday

InnSuites Hospitality Trust Shares of Beneficial Interest

InnSuites Hospitality Trust

Invesco High Income 2024 Target Term Fund Common Shares of Beneficial Interest, No par value per share

Invesco High Income 2024 Target Term

INTEGRATIVE HLTH TCHS INC by Integrative Health Technologies, Inc.

Integrative Health Technologies Inc

Consolidated Net Income before non-cash depreciation expense was&nbsp;$14,693&nbsp;for the 2025 Fiscal First Half ended July 31, 2024 (February 1, 2024, through July 31, 2024).

Earnings

InnSuites Hospitality Trust H1 Total Revenue Increase To An Approximately $4.1M

As of June 17, 2024, four stocks in the real estate sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the <a href="https://www.benzinga.com/topic/rsi">RSI is above 70</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>. 
Here's the latest list of major overbought players in this sector.
<h3 class="wp-block-heading">Essex Property Trust Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ESS#NYSE">ESS</a>)</h3>
<ul>
<li>On June 14, Scotiabank analyst Nicholas Yulico maintained Essex Property Trust with a Sector Outperform and raised the price target from $283 to $285. The company's stock gained around 4% over the past five days and has a <a href="https://www.benzinga.com/quote/ESS">52-week high of $279.09</a>.</li>
<li>RSI Value: 71.28&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
<li>ESS Price Action: Shares of Essex Property Trust rose 1.2% to close at $278.50 on Friday.</li>
</ul>
<h3 class="wp-block-heading">InnSuites Hospitality Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IHT#NYSE">IHT</a>)</h3>
<ul>
<li>On Jan. 8, InnSuites Hospitality Trust announced a semi-annual dividend of 1 cent per share after clocking December revenue of $0.52 million. The company's stock gained around 31% over the past month and <a href="https://www.benzinga.com/quote/IHT">has a 52-week high</a> of $3.62.</li>
<li>RSI Value: 78.37</li>
<li>IHT Price Action: Shares of InnSuites Hospitality Trust fell 2.2% to close at $1.75 on Friday.</li>
</ul>
<h3 class="wp-block-heading">Iron Mountain Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IRM#NYSE">IRM</a>)</h3>
<ul>
<li>On May 2, the company, under the helm of CEO William Meaney, reported first-quarter adjusted earnings per share of 43 cents. Quarterly revenue of $1.477 billion, beating the street view of $1.453 billion. Iron Mountain declared a quarterly cash dividend of 65 cents per share for the second quarter, which is payable on July 5, 2024, for shareholders of record on June 17, 2024. The company's stock gained around 7% over the past month and has a <a href="https://www.benzinga.com/quote/IRM">52-week high</a> of $89.91.</li>
<li>RSI Value: 74.06</li>
<li>IRM Price Action: Shares of Iron Mountain gained 0.3% to close at $88.02 on Friday.</li>
</ul>
National Storage Affiliates Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NSA#NYSE">NSA</a>)
<ul>
<li>On May 1, National Storage posted weaker-than-expected quarterly sales. The company's stock jumped around 6% over the past five days and has a 52-week high of $42.54.</li>
<li>RSI Value: 73.81</li>
<li>NSA Price Action: Shares of National Storage Affiliates Trust gained 0.4% to close at $40.85 on Friday.</li>
</ul>
Check This Out: <a href="https://www.benzinga.com/news/24/06/39331770/wall-streets-most-accurate-analysts-weigh-in-on-3-tech-stocks-with-over-3-dividend-yields">Wall Street&#8217;s Most Accurate Analysts Weigh In On 3 Tech Stocks With Over 3% Dividend Yields</a>

Guidance

InnSuites Hospitality Trust  Said We Anticipate Limited Additional New-build Hotel Supply In Our Markets During The Current Fiscal Year 2025, And Accordingly We Anticipate A Continued Increase Of Revenues And Operating Margins

InnSuites Hospitality Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IHT#NYSE">IHT</a>)&nbsp;On January 5, 2024, the Board of Trustees of InnSuites Hospitality Trust (NYSE Am:&nbsp;<a href="https://www.benzinga.com/stock/iht#NYSE%20Am">IHT</a>), announced a semi-annual dividend of&nbsp;$0.01&nbsp;per share payable on February 5, 2024, to shareholders of record as of January 22, 2024, extending an uninterrupted continuous 54-year history of annual dividends. InnSuites hotel operations revenue continues to grow, with the highest combined hotel revenue total ever in December for IHT hotels at&nbsp;$524,219. The UniGen diversified efficient clean energy investment continues to progress, while seeking additional funding.

Dividends

InnSuites Hospitality Trust Announced a Semi-Annual Dividend of $0.01/Share After Clocking December Revenue of $0.52M

Shares of Reneo Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rphm#NASDAQ">RPHM</a>) shares rose sharply during Wednesday&rsquo;s session after Concentra sent an acquisition proposal to acquire 100% of equity of the company for $1.80 per share.
Reneo Pharmaceuticals shares climbed 13.6% to $1.59 on Wednesday.
Here are some other stocks moving in today&#39;s mid-day session.
<h3>Gainers</h3>
<ul>
<li>First Wave BioPharma, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/fwbi#NASDAQ">FWBI</a>) shares jumped 169% to $9.90 after the company announced that it entered a non-binding term sheet to sell its Niclosamide program for the treatment of inflammatory bowel diseases.</li>
<li>Cingulate Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cing#NASDAQ">CING</a>) gained 95.2% to $4.08.</li>
<li>RiskOn International, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/roi#NASDAQ">ROI</a>) shares climbed 91.8% to $0.27. RiskOn International expects to announce its new generative AI platform and technology partner on Jan. 3, 2024.</li>
<li>Cytokinetics, Incorporated (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cytk#NASDAQ">CYTK</a>) surged 64.2% to $75.05 after the company announced topline results from SEQUOIA-HCM, the Phase 3 clinical trial of aficamten in patients with symptomatic obstructive hypertrophic cardiomyopathy.</li>
<li>AEye, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lidr#NASDAQ">LIDR</a>) rose 61.2% to $3.58.</li>
<li>Vince Holding Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/vnce#NYSE">VNCE</a>) jumped 42% to $3.2399.</li>
<li>Bit Brother Limited(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bets#NASDAQ">BETS</a>) gained 38.2% to $0.0152 after jumping 111% on Tuesday.</li>
<li>Nxu, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nxu#NASDAQ">NXU</a>) rose 34% to $4.18.</li>
<li>Virax Biolabs Group Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vrax#NASDAQ">VRAX</a>) gained 32% to $1.7551.</li>
<li>Jet.AI Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/jtai#NASDAQ">JTAI</a>) shares gained 28% to $2.05 after falling 39% on Tuesday.</li>
<li>Elicio Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/eltx#NASDAQ">ELTX</a>) jumped 25% to $8.89. Elicio Therapeutics 10% owner GKCC, LLC acquired a total of 1,213,000 shares an average price of $5.81.</li>
<li>Matinas BioPharma Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mtnb#NASDAQ">MTNB</a>) gained 24.7% to $0.2518 after the company announced results from a series of in vivo studies demonstrating oral delivery of two LNC-formulated small single-strand oligonucleotides.</li>
<li>Coherus BioSciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/chrs#NASDAQ">CHRS</a>) shares rose 23.8% to $2.70 after the company reported the FDA approval of UDENYCA ONBODY for pegfilgrastim-cbqv.</li>
<li>TeraWulf Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wulf#NASDAQ">WULF</a>) gained 21.3% to $2.6950 after gaining 3% on Tuesday.</li>
<li>Jiuzi Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/jzxn#NASDAQ">JZXN</a>) rose 15.2% to $0.7322.</li>
<li>Burford Capital Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bur#NYSE">BUR</a>) gained 14.3% to $15.44.</li>
<li>Edgewise Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ewtx#NASDAQ">EWTX</a>) climbed 13.8% to $10.84.</li>
<li>Mobile Global Esports Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mgam#NASDAQ">MGAM</a>) shares rose 13.8% to $0.4380 after gaining 33% on Tuesday.</li>
<li>Wheels Up Experience Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/up#NYSE">UP</a>) gained 12.8% to $4.74.</li>
<li>Organogenesis Holdings Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/orgo#NASDAQ">ORGO</a>) surged 12.2% to $4.4550. BTIG maintained Organogenesis with a Buy and raised the price target from $4 to $6.</li>
<li>Ascent Industries Co. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/acnt#NASDAQ">ACNT</a>) rose 11.9% to $9.05 as the company reported the sale of the business of Specialty Pipe &amp; Tube for around $55 million in an all-cash deal.</li>
<li>Mynd.ai, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mynd#NYSE">MYND</a>) gained 10.4% to $5.20.</li>
<li>Coinbase Global, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/coin#NASDAQ">COIN</a>) surged 7.4% to $184.89.</li>
<li>Li Auto Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/li#NASDAQ">LI</a>) gained 5.1% to $36.20.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>Hallmark Financial Services, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hall#NASDAQ">HALL</a>) shares fell 31.4% to $1.0764. Hallmark Financial Services gave notice to Nasdaq of intention to voluntarily delist its shares of common stock from Nasdaq Global Market.</li>
<li>Baosheng Media Group Holdings Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/baos#NASDAQ">BAOS</a>) fell 29.5% to $4.1050.</li>
<li>Nukkleus Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nukk#NASDAQ">NUKK</a>) shares fell 28.8% to $2.60 after jumping around 11% on Tuesday.</li>
<li>Iovance Biotherapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/iova#NASDAQ">IOVA</a>) fell 20.4% to $7.07 after the FDA placed a clinical hold on the IOV-LUN-202 trial in response to a recently reported Grade 5 adverse event potentially related to the non-myeloablative lymphodepletion pre-conditioning regimen.</li>
<li>Mobix Labs, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mobx#NASDAQ">MOBX</a>) shares fell 17.1% to $5.80 after surging over 34% on Tuesday.</li>
<li>Color Star Technology Co., Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/add#NASDAQ">ADD</a>) dipped 15.4% to $0.33.</li>
<li>Bluejay Diagnostics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bjdx#NASDAQ">BJDX</a>) fell 15.4% to $2.20. Bluejay Diagnostics announced initiation of multicenter clinical study evaluating symphony IL-6 in sepsis patients.</li>
<li>Golden Heaven Group Holdings Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gdhg#NASDAQ">GDHG</a>) declined 15% to $0.7880.</li>
<li>ARB IOT Group Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/arbb#NASDAQ">ARBB</a>) fell 14.4% to $2.2155 after surging 175% on Tuesday.</li>
<li>Asset Entities Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/asst#NASDAQ">ASST</a>) declined 13.7% to $0.6120.</li>
<li>Volcon, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vlcn#NASDAQ">VLCN</a>) fell 12.7% to $0.1224. On Dec 19, Volcon got deficiency letter from Nasdaq that the company did not meet minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2).</li>
<li>Smart for Life, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/smfl#NASDAQ">SMFL</a>) shares fell 10.8% to $1.63 after declining 7% on Tuesday.</li>
<li>Brainstorm Cell Therapeutics Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bcli#NASDAQ">BCLI</a>) shares fell 9.1% to $0.2090. Brainstorm Cell Therapeutics shares gained 16% on Tuesday after the company announced that it was granted patents for Allogeneic Exosome Platform-Product in neurological disorder treatments.</li>
<li>Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/iinn#NASDAQ">IINN</a>) shares fell 8.7% to $1.16. Inspira Technologies shares gained 5% on Tuesday after the company announced 95% accuracy results for HYLA Blood Sensor. Additionally, the company plans FDA submission for clearance in 2024.</li>
<li>InnSuites Hospitality Trust (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/iht#NYSE">IHT</a>) fell 8.6% to $1.4250.</li>
<li>Oncternal Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/onct#NASDAQ">ONCT</a>) shares fell 6.8% to $0.5510. Oncternal Therapeutics updated the status of a recent study involving a treatment for relapsed or refractory aggressive B-cell lymphoma, including patients who have failed previous CD19 CAR-T treatment.</li>
<li>Canopy Growth Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cgc#NASDAQ">CGC</a>) fell 6.2% to $5.31.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/news/23/12/36395783/amazon-adobe-and-2-other-stocks-insiders-are-selling"> Amazon, Adobe And 2 Other Stocks Insiders Are Selling</a>

Why Reneo Pharmaceuticals Shares Are Trading Higher By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

U.S. stocks traded mostly higher, with the Dow Jones index gaining around 80 points on Wednesday.
Shares of Iovance Biotherapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/iova#NASDAQ">IOVA</a>) fell sharply during Wednesday&rsquo;s session after the company announced a clinical program update for LN-145 TIL therapy in non-small lung cancer (NSCLC).
The FDA placed a clinical hold on the IOV-LUN-202 trial on December 22, 2023, in response to a recently reported Grade 5 (fatal) serious adverse event potentially related to the non-myeloablative lymphodepletion pre-conditioning regimen. 
Iovance Biotherapeutics shares dipped 20.4% to $7.07 on Wednesday.
Here are some other big stocks recording gains in today&rsquo;s session.
<ul>
<li>Nukkleus Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nukk#NASDAQ">NUKK</a>) shares declined 28.8% to $2.60 after jumping around 11% on Tuesday.</li>
<li>GreenTree Hospitality Group Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ghg#NYSE">GHG</a>) fell 10% to $3.69.</li>
<li>InnSuites Hospitality Trust (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/iht#NYSE">IHT</a>) dipped 8.6% to $1.4250.</li>
<li>LanzaTech Global, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lnza#NASDAQ">LNZA</a>) fell 7.6% to $5.00.</li>
<li>Life Time Group Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/lth#NYSE">LTH</a>) fell 6.9% to $14.30. On Dec 22, Life Time Group Holdings agreed with company&rsquo;s CFO, Robert Houghton that he will resign as CFO.</li>
<li>Cheche Group Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ccg#NASDAQ">CCG</a>) fell 6.3% to $6.51.</li>
<li>Canopy Growth Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cgc#NASDAQ">CGC</a>) declined 6.2% to $5.31.</li>
<li>Velocity Financial, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/vel#NYSE">VEL</a>) fell 4.8% to $15.62.</li>
<li>The Beauty Health Company (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/skin#NASDAQ">SKIN</a>) fell 4.8% to $3.0850.</li>
<li>NetEase, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ntes#NASDAQ">NTES</a>) fell 4.2% to $88.30 on continued volatility amid regulatory developments in China&#39;s gaming sector.</li>
<li>NIO Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nio#NYSE">NIO</a>) fell 4.1% to $8.95 after rising more than 10% on Tuesday. Nio stock raced higher to start the week after the company launched its new ET9 sedan at its Nio Day event over the weekend.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/markets/cryptocurrency/23/12/36397627/ethereum-moves-higher-bitcoin-sv-emerges-as-top-gainer"> Ethereum Moves Higher; Bitcoin SV Emerges As Top Gainer </a>

Although U.S. stocks closed mixed on Friday, there were a few notable insider trades.
When insiders purchase shares, it indicates their confidence in the company&#39;s prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision.
Below is a look at a few recent notable insider purchases. For more, check out <a href="https://www.benzinga.com/sec/insider-trades/"> Benzinga&#39;s insider transactions </a> platform.
<h3>InnSuites Hospitality Trust </h3>
<ul>
<li>The Trade: InnSuites Hospitality Trust (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/iht#NYSE">IHT</a>) President and CEO James F Wirth <a href="https://www.benzinga.com/quote/IHT/analyst-ratings"> acquired a total of 2,000 shares </a> an average price of $2,809.35. To acquire these shares, it cost around $5.62 million.</li>
<li>What&rsquo;s Happening: InnSuites Hospitality recently reported an increase in quarterly sales.</li>
<li>What InnSuites Hospitality Trust Does: InnSuites Hospitality Trust is a real estate investment trust. It is engaged in the ownership and operation of hotel properties.</li>
</ul>
<h3>Astria Therapeutics </h3>
<ul>
<li>The Trade: Astria Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/atxs#NASDAQ">ATXS</a>) Director Joseph Edelman acquired a total of 740,000 shares at an average price of $6.20. To acquire these shares, it cost around $4.59 million.</li>
<li>What&rsquo;s Happening: Astria Therapeutics, last month, posted a narrower quarterly loss.</li>
<li>What Astria Therapeutics Does: Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases.</li>
</ul>
Don&rsquo;t forget to check out our <a href="https://www.benzinga.com/premarket/"> premarket coverage here </a> 
<h3>Steel Connect </h3>
<ul>
<li>The Trade: Steel Connect, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/stcn#NASDAQ">STCN</a>) 10% owner WF Asset Corp. <a href="https://www.benzinga.com/sec/insider-trades/"> bought a total of 9,437 shares </a> at an average price of $9.60. To acquire these shares, it cost around $90,628.</li>
<li>What&rsquo;s Happening: Steel Connect recently reported a decline in quarterly sales.</li>
<li>What Steel Connect Does: Steel Connect Inc is a diversified holding company. The company&#39;s operating segment include Direct Marketing and Supply Chain.</li>
</ul>
&nbsp;
Check This Out: <a href="https://www.benzinga.com/news/23/12/36342622/top-5-industrials-stocks-that-are-ticking-portfolio-bombs"> Top 5 Industrials Stocks That Are Ticking Portfolio Bombs </a>

Long Ideas

Insider Trades

ATXS

STCN

$5.6M Bet On This Real Estate Stock? Check Out These 3 Stocks Insiders Are Buying

InnSuites Hospitality (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/IHT#AMEX">IHT</a>) reported $1.82 million in sales this quarter. This is a 7.01 percent increase over sales of $1.71 million the same period last year.

InnSuites Hospitality Q3 Sales $1.82M Up From $1.71M YoY

Gainers
TransCode Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rnaz#NASDAQ">RNAZ</a>) shares jumped 308% to $2.71 after the company announced pre-clinical gliblastoma results with its lead candidate, TTX-MC138.
FaZe Holdings Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/faze#NASDAQ">FAZE</a>) gained 46.9% to $0.2247 after falling over 4% on Friday.
Avalo Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/avtx#NASDAQ">AVTX</a>) shares climbed 23.5% to $0.1472 after gaining 16% on Friday. The company recently announced the sale of its assets relating to AVTX-801 (D-galactose), AVTX-802 (D-mannose) and AVTX-803 (L-fucose) on Sept. 12.
Biophytis S.A. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bpts#NASDAQ">BPTS</a>) shares gained 22.3% to $1.1250 after the company and Skyepharma announced the signature of a partnership agreement for the production of regulatory batches of Sarconeos (BIO101) for severe forms of Covid-19.
Cano Health, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cano#NYSE">CANO</a>) rose 20.5% to $0.2727.
Sharps Technology, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/stss#NASDAQ">STSS</a>) surged 18.2% to $0.6703.
CalciMedica, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/calc#NASDAQ">CALC</a>) climbed 16.3% to $3.0699.
TradeUP Acquisition Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/uptd#NASDAQ">UPTD</a>) gained 14% to $14.50
So-Young International Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sy#NASDAQ">SY</a>) gained 13.5% to $1.2263.
Shattuck Labs, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sttk#NASDAQ">STTK</a>) rose 13.3% to $1.71.
Pasithea Therapeutics Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ktta#NASDAQ">KTTA</a>) gained 13.1% to $0.4998.
Enthusiast Gaming Holdings Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/eglx#NASDAQ">EGLX</a>) gained 12.7% to $0.3367.
InnSuites Hospitality Trust (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/iht#NYSE">IHT</a>) surged 12.5% to $1.4399.
Canopy Growth Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cgc#NASDAQ">CGC</a>) rose 12.5% to $0.9422.
ESS Tech, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/gwh#NYSE">GWH</a>) shares climbed 10.1% to $1.53. Honeywell International Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hon#NASDAQ">HON</a>) entered into a strategic collaboration with ESS Tech to advance technology development and market adoption of iron flow battery (IFB) energy storage systems.
Solo Brands, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/dtc#NYSE">DTC</a>) gained 10% to $4.9605. Craig-Hallum initiated coverage on Solo Brands with a Buy rating and announced a price target of $8.
Sea Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/se#NYSE">SE</a>) surged 9.7% to $39.46.
MDB Capital Holdings, LLC (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mdbh#NASDAQ">MDBH</a>) gained 9.5% to $11.51.
Williams-Sonoma, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/wsm#NYSE">WSM</a>) surged 8.9% to $152.52 after a 13G filing showed Green Equity Investors IX, L.P. increased its stake in the company to 5%.
Bridger Aerospace Group Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/baer#NASDAQ">BAER</a>) rose 8.8% to $8.40.
MIRA Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mira#NASDAQ">MIRA</a>) shares surged 7.5% to $5.02 after gaining 4% on Friday.
Energy Fuels Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/uuuu#NASDAQ">UUUU</a>) gained 5.6% to $8.66.
Losers
SCYNEXIS, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/scyx#NASDAQ">SCYX</a>) shares declined 35.9% to $1.9350 after the company announced it is recalling BREXAFEMME and temporarily halting clinical studies of ibrexafungerp due to the risk of cross contamination with a non-bacterial beta-lactam drug substance during the manufacturing process.
MicroAlgo Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mlgo#NASDAQ">MLGO</a>) fell 34.5% to $3.13. MicroAlgo shares jumped 110% on Friday after it unveiled a knowledge-enhanced backtracking search algorithm to boost the performance and efficiency of research institutions.
Turbo Energy, S.A. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/turb#NASDAQ">TURB</a>) fell 33.1% to $3.35. Turbo Energy reported pricing of IPO at $5.00 per ADS.
Brainstorm Cell Therapeutics Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bcli#NASDAQ">BCLI</a>) fell 32.6% to $0.5498 after the FDA said it does not believe there is sufficient evidence to support that any of the assessed biomarkers for the company&#39;s ALS therapy is reasonably likely to predict clinical benefit.
Calidi Biotherapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cldi#NASDAQ">CLDI</a>) declined 23.2% to $ 3.1117.
Rite Aid Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/rad#NYSE">RAD</a>) shares fell 22% to $0.4601. Rite Aid is looking to close hundreds of stores in bankruptcy, the Wall Street Journal reported.
Safe &amp; Green Holdings Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sgbx#NASDAQ">SGBX</a>) shares fell 21.3% to $1.1095 after dipping 22% on Friday.
Blue Star Foods Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bsfc#NASDAQ">BSFC</a>) declined 19.4% to $0.2333.
GSE Systems, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gvp#NASDAQ">GVP</a>) fell 17.7% to $0.2468.
Morphic Holding, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/morf#NASDAQ">MORF</a>) declined 17.4% to $30.25 after BTIG downgraded the stock from Buy to Neutral.
Solowin Holdings (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/swin#NASDAQ">SWIN</a>) fell 16.5% to $3.09 after declining around 9% on Friday.
Pineapple Energy Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pegy#NASDAQ">PEGY</a>) declined 15.4% to $0.8134.
Faraday Future Intelligent Electric Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ffie#NASDAQ">FFIE</a>) fell 15% to $3.33.
AgriFORCE Growing Systems Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/agri#NASDAQ">AGRI</a>) declined 14.6% to $0.1123.
Alector, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/alec#NASDAQ">ALEC</a>) fell 14.4% to $5.89 after Goldman Sachs initiated coverage on the stock with a Sell rating and $4 price target.
Connexa Sports Technologies Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cnxa#NASDAQ">CNXA</a>) dropped 13.8% to $4.5499 after the company announced that it received a letter from the Nasdaq regarding the late filing of its quarterly report.
CF Acquisition Corp. VIII (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cffe#NASDAQ">CFFE</a>) fell 12.2% to $14.35 after gaining 13% on Friday.
Li Auto Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/li#NASDAQ">LI</a>) fell 8.6% to $35.87.
Tarena International, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tedu#NASDAQ">TEDU</a>) fell 8.5% to $1.9201.
VinFast Auto Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vfs#NASDAQ">VFS</a>) fell 8.5% to $14.25.
LivePerson, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lpsn#NASDAQ">LPSN</a>) fell 8.3% to $4.06.
Editas Medicine, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/edit#NASDAQ">EDIT</a>) dipped 8.2% to $7.21.
Coherus BioSciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/chrs#NASDAQ">CHRS</a>) fell 6.8% to $4.1550. Coherus BioSciences announced the FDA issued a complete response letter for UDENYCA ONBODY biologics license application solely due to an ongoing review of inspection findings at a third-party filler.
Hawaiian Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ha#NASDAQ">HA</a>) declined 6.6% to $6.37. Hawaiian Holdings sees third-quarter ASMs up 4.0% to up 5.5%.
Alcoa Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/aa#NYSE">AA</a>) fell 6.2% to $26.58. Alcoa disclosed the appointment of William F. Oplinger as President and Chief Executive Officer and as a member of its Board of Directors, effective September 24, 2023.
Now Read This: <a href="https://www.benzinga.com/news/23/09/34861974/baidu-to-rally-over-29-here-are-10-other-analyst-forecasts-for-monday"> Baidu To Rally Over 29%? Here Are 10 Other Analyst Forecasts For Monday</a>

AGRI

ALEC

AVTX

BAER

BPTS

BSFC

CALC

CANO

CFFE

CLDI

CONNEXA SPORTS TECH INC by Connexa Sports Technologies Inc.

CNXA

EDIT

EGLX

FAZE

FFIE

KTTA

LPSN

MDBH

MIRA

MLGO

MORF

PEGY

RNAZ

SCYX

SGBX

STSS

STTK

SWIN

TEDU

TURB

UPTD

UUUU

Why Brainstorm Cell Therapeutics Shares Are Trading Lower By 33%? Here Are Other Stocks Moving In Monday's Mid-Day Session

<h3>Gainers</h3>
<ul>
<li>American Rebel Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/areb#NASDAQ">AREB</a>) shares jumped 100% to $1.7909 after the company&#39;s subsidiary Champion Safe has been bombarded with calls from safe dealers and customers looking for alternatives to safes made by Liberty Safe.</li>
<li>Wheeler Real Estate Investment Trust, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/whlr#NASDAQ">WHLR</a>) jumped 86.1% to $8.45. Wheeler posted Series D redemption forms on its website.</li>
<li>Sigma Additive Solutions, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sasi#NASDAQ">SASI</a>) shares jumped 68% to $0.3578 after the company announced to acquire NextTrip for around $48 million and sell assets of quality assurance software to strategic buyer.</li>
<li>Rosecliff Acquisition Corp I (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rclf#NASDAQ">RCLF</a>) gained 48.4% to $15.34.</li>
<li>China SXT Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sxtc#NASDAQ">SXTC</a>) shares jumped 26.5% to $0.1512 after declining 7% on Wednesday.</li>
<li>Hitek Global Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hkit#NASDAQ">HKIT</a>) shares jumped 25% to $4.50 after falling 87% on Wednesday.</li>
<li>Semantix, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/stix#NASDAQ">STIX</a>) gained 20% to $1.39.</li>
<li>Asensus Surgical, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/asxc#NYSE">ASXC</a>) surged 18.7% to $0.3443 after the company collaborated with NVIDIA for Asensus&#39;s Intelligent Surgical Unit.</li>
<li>Designer Brands Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/dbi#NYSE">DBI</a>) gained 16% to $12.06 after the company reported upbeat second-quarter results.</li>
<li>G-III Apparel Group, Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/giii#NASDAQ">GIII</a>) surged 13.7% to $21.95 after the company reported upbeat second-quarter results.</li>
<li>InnSuites Hospitality Trust (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/iht#NYSE">IHT</a>) jumped 13.2% to $1.67.</li>
<li>Calavo Growers, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cvgw#NASDAQ">CVGW</a>) gained 12.8% to $35.26 after the company reported third-quarter results.</li>
<li>PARTS iD, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/id#NYSE">ID</a>) climbed 12.8% to $0.2650.</li>
<li>InnSuites Hospitality Trust (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/iht#NYSE">IHT</a>) rose 12.5% to $1.66.</li>
<li>DatChat, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dats#NASDAQ">DATS</a>) surged 12% to $0.5479.</li>
<li>ATIF Holdings Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/atif#NASDAQ">ATIF</a>) gained 12% to $1.45.</li>
<li>Artelo Biosciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/artl#NASDAQ">ARTL</a>) shares rose 8.5% to $2.55. Artelo Biosciences has completed a pre-IND (Investigational New Drug) meeting with the FDA regarding the development plan for ART26.12.</li>
<li>Couchbase, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/base#NASDAQ">BASE</a>) climbed 5.9% to $17.47 following second-quarter results.</li>
<li>WestRock Company (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/wrk#NYSE">WRK</a>) gained 5.6% to $33.68 after the company said it is discussing terms of a potential combination with Smurfit Kappa Group.</li>
<li>UiPath Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/path#NYSE">PATH</a>) gained 5.5% to $17.11 as the company reported better-than-expected second-quarter results.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>Palisade Bio, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pali#NASDAQ">PALI</a>) shares dipped 44.1% to $0.8050 after the company announced $2 million registered direct offering.</li>
<li>Edible Garden AG Incorporated (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/edbl#NASDAQ">EDBL</a>) shares fell 35.8% to $0.8350 after the company reported pricing of $3.0 million underwritten public offering.</li>
<li>Sportsman&#39;s Warehouse Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/spwh#NASDAQ">SPWH</a>) fell 32.4% to $3.0432 after the company reported worse-than-expected second-quarter earnings.</li>
<li>Inspire Veterinary Partners, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ivp#NASDAQ">IVP</a>) dipped 31% to $1.89.</li>
<li>ChargePoint Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/chpt#NYSE">CHPT</a>) shares fell 24.6% to $5.32 on the heels of the company&#39;s second-quarter results.</li>
<li>SIGNA Sports United N.V. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ssu#NYSE">SSU</a>) tumbled 24% to $0.5106.</li>
<li>NeuBase Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nbse#NASDAQ">NBSE</a>) fell 22.2% to $1.85 possibly on profit taking after the stock rallied roughly 100% yesterday after Symetryx taking a 20% stake in NBSE stock.</li>
<li>Yext, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/yext#NYSE">YEXT</a>) shares fell 21.5% to $7.13 after the company reported mixed second-quarter earnings.</li>
<li>Corvus Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/crvs#NASDAQ">CRVS</a>) dipped 19.2% to $1.69. Corvus Pharmaceuticals confirmed planned initiation of soquelitinib Phase 3 registrational clinical trial in peripheral T cell lymphoma following meeting with the FDA.</li>
<li>ThredUp Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tdup#NASDAQ">TDUP</a>) declined 18.8% to $3.23.</li>
<li>Cardio Diagnostics Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cdio#NASDAQ">CDIO</a>) fell 18.8% to $0.41. Cardio Diagnostics and Truckers Health Network entered into a strategic collaboration.</li>
<li>Torrid Holdings Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/curv#NYSE">CURV</a>) fell 18.2% to $1.80 following weak quarterly earnings.</li>
<li>Methode Electronics, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mei#NYSE">MEI</a>) tumbled 16.4% to $25.09 after the company reported mixed first-quarter results and dismal second-quarter guidance.</li>
<li>Amkor Technology, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/amkr#NASDAQ">AMKR</a>) fell 16.4% to $22.80. Amkor Technology priced secondary offering of 10 million common shares by The Kim Family at $24 per share.</li>
<li>C3.ai, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ai#NYSE">AI</a>) shares fell 16.4% to $26.31 following quarterly results.</li>
<li>Phreesia, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/phr#NYSE">PHR</a>) tumbled 15.6% to $25.60 after the company released mixed second-quarter earnings.</li>
<li>BlackBerry Ltd (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bb#NYSE">BB</a>) fell 15.5% to $4.68. BlackBerry said it sees a 21.4% decline in its revenue for the second quarter.</li>
<li>DIRTT Environmental Solutions Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/drtt#NASDAQ">DRTT</a>) fell 14.9% to $0.2721. DIRTT to voluntarily delist from the Nasdaq Exchange.</li>
<li>ABM Industries Incorporated (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/abm#NYSE">ABM</a>) declined 14.6% to $38.23 after the company reported mixed third-quarter results and lowered the top end of its FY23 guidance range.</li>
<li>Verint Systems Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vrnt#NASDAQ">VRNT</a>) shares fell 14.3% to $26.44 following weak quarterly results.</li>
<li>PaxMedica, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pxmd#NASDAQ">PXMD</a>) fell 13.9% to $0.3409 after declining 8% on Wednesday.</li>
<li>The Toro Company (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ttc#NYSE">TTC</a>) declined 13.7% to $85.98 after the company reported worse-than-expected third-quarter results and cut its FY23 guidance.</li>
<li>Intapp, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/inta#NASDAQ">INTA</a>) fell 12.1% to $32.75 following quarterly results.</li>
<li>FOXO Technologies Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/foxo#NYSE">FOXO</a>) declined 11.5% to $0.1448. FOXO Technologies&rsquo; FOXO LIFE subsidiary announced an agreement with Atrio, expanding its distribution through Atrio/Singular&#39;s sales network.</li>
<li>Tandem Diabetes Care, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tndm#NASDAQ">TNDM</a>) fell 10.7% to $25.13.</li>
<li>The Greenbrier Companies, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/gbx#NYSE">GBX</a>) dipped 9.6% to $37.62. Wells Fargo downgraded Greenbrier Companies from Overweight to Equal-Weight and lowered the price target from $48 to $40.</li>
<li>3D Systems Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ddd#NYSE">DDD</a>) fell 9.3% to $5.20.</li>
<li>Uniti Group Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/unit#NASDAQ">UNIT</a>) dropped 8.8% to $4.8850.</li>
<li>Insulet Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/podd#NASDAQ">PODD</a>) dipped 8.8% to $176.26 after UBS lowered the price target from $270 to $215.</li>
<li>Seagate Technology Holdings plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/stx#NASDAQ">STX</a>) fell 8.4% to $65.19 after Barclays downgraded the stock from Overweight to Equal-Weight. Seagate Technology&#39;s Seagate HDD Cayman to offer $1.3 billion in exchangeable senior notes due 2028 in a private placement.</li>
<li>Qudian Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/qd#NYSE">QD</a>) fell 8.4% to $2.17 after reporting weak second-quarter results.</li>
<li>Rollins, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/rol#NYSE">ROL</a>) shares declined 8.3% to $34.92 after the company announced pricing of secondary public offering of common stock.</li>
<li>AMC Entertainment Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/amc#NYSE">AMC</a>) fell 8.1% to $7.92. AMC Entertainment shares fell sharply on Wednesday after the company entered an equity distribution agreement for up to 40 million shares at an at-the-market program.</li>
<li>Neogen Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/neog#NASDAQ">NEOG</a>) fell 6.6% to $20.83 after the company disclosed modestly negative core growth, slightly below expectations for the first quarter.</li>
<li>Tutor Perini Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tpc#NYSE">TPC</a>) declined 5.3% to $8.20.</li>
<li>Dave &amp; Buster&#39;s Entertainment, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/play#NASDAQ">PLAY</a>) shares tumbled 4.1% to $35.88 after the company reported second-quarter financial results.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/trading-ideas/long-ideas/23/09/34316923/wall-streets-most-accurate-analysts-say-buy-these-3-consumer-stocks-delivering-high-divi"> Wall Street&#39;s Most Accurate Analysts Say Buy These 3 Consumer Stocks Delivering High-Dividend Yields </a>

AMKR

AREB

ARTL

ASXC

ATIF

BASE

Cardio Diagnostics Holdings Inc. - Common stock

CDIO

CHPT

CRVS

CURV

CVGW

DATS

DRTT

EDBL

FOXO

GIII

HKIT

INTA

NBSE

NEOG

PALI

PATH

PLAY

PODD

PXMD

RCLF

SASI

SPWH

STIX

SXTC

TDUP

TNDM

UNIT

VRNT

WHLR

YEXT

Why Toro Are Trading Lower By 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

<h3>Gainers</h3>
<ul>
<li>Alset Capital Acquisition Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/acax#NASDAQ">ACAX</a>) shares climbed 66.2% to $12.93.</li>
<li>YS Biopharma Co., Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ys#NASDAQ">YS</a>) shares jumped 57% to $1.1850 after the company announced the purchase of shares by company officers.</li>
<li>Crown ElectroKinetics Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/crkn#NASDAQ">CRKN</a>) jumped 42.1% to $1.7757 after falling over 9% on Thursday. The company, on Thursday, issued a second-quarter business update.</li>
<li>Cano Health, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cano#NYSE">CANO</a>) surged 41% to $0.3250. Cano Health recently appointed Mark Kent as permanent Chief Executive Officer.</li>
<li>Affirm Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/afrm#NASDAQ">AFRM</a>) gained 24.7% to $17.23 after the company reported better-than-expected fourth-quarter financial results and issued guidance.</li>
<li>VinFast Auto Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vfs#NASDAQ">VFS</a>) jumped 24% to $61.00.</li>
<li>Hibbett, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hibb#NASDAQ">HIBB</a>) gained 21.8% to $44.88 following upbeat quarterly earnings.</li>
<li>Lendway, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ldwy#NASDAQ">LDWY</a>) jumped 19.4% to $5.06.</li>
<li>InnSuites Hospitality Trust (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/iht#NYSE">IHT</a>) gained 18.6% to $1.7082.</li>
<li>Genius Group Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/gns#NYSE">GNS</a>) surged 17.7% to $1.33.</li>
<li>Precigen, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pgen#NASDAQ">PGEN</a>) jumped 15.7% to $1.77.</li>
<li>Bionomics Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bnox#NASDAQ">BNOX</a>) surged 15.4% to $1.7305.</li>
<li>American Software, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/amswa#NASDAQ">AMSWA</a>) gained 10% to $11.81 following upbeat quarterly earnings.</li>
<li>Better Home &amp; Finance Holding Co (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/betr#NASDAQ">BETR</a>) shares rose 7.8% to $1.2398 after dipping 93% on Thursday.</li>
<li>Spark Networks SE (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lov#NASDAQ">LOV</a>) shares surged 7.8% to $0.2048 after declining 6% on Thursday.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>Domo, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/domo#NASDAQ">DOMO</a>) shares fell 42.4% to $9.81 after it issued a below-consensus third-quarter outlook and lowered FY24 guidance.</li>
<li>Prime Number Acquisition I Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pnac#NASDAQ">PNAC</a>) fell 36.2% to $5.12. noco-noco Pte. Ltd and Prime Number Acquisition I Corp announced that the parties plan to close the business combination on Aug. 25, 2023.</li>
<li>Allego N.V. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/allg#NYSE">ALLG</a>) fell 20.6% to $1.7050 after the company announced the commencement of an exchange offer and a consent solicitation of &euro;0.12 per share.</li>
<li>Bruush Oral Care Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/brsh#NASDAQ">BRSH</a>) shares fell 19.7% to $2.1673 after jumping 56% on Thursday.</li>
<li>Hawaiian Electric Industries, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/he#NYSE">HE</a>) fell 15.3% to $10.05. Hawaiian Electric plans to suspend quarterly cash dividend on common stock, beginning with the third quarter of 2023.</li>
<li>Recruiter.com Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rcrt#NASDAQ">RCRT</a>) dipped 15% to $1.81.</li>
<li>Mercurity Fintech Holding Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mfh#NASDAQ">MFH</a>) declined 14.7% to $1.39.</li>
<li>Ideanomics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/idex#NASDAQ">IDEX</a>) shares fell 14.5% to $3.70 after dipping 10% on Thursday. The company recently announced a 1-for-125 reverse stock split.</li>
<li>Minerva Surgical, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/utrs#NASDAQ">UTRS</a>) fell 14.1% to $0.2098 after jumping 16% on Thursday.</li>
<li>Electriq Power Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/eliq#NYSE">ELIQ</a>) fell 14.1% to $2.56.</li>
<li>Nemaura Medical Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nmrd#NASDAQ">NMRD</a>) dipped 12.2% to $0.5176.</li>
<li>RiceBran Technologies (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ribt#NASDAQ">RIBT</a>) declined 11.8% to $0.52.</li>
<li>Gaucho Group Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vino#NASDAQ">VINO</a>) fell 11.2% to $0.3996 after gaining 9% on Thursday.</li>
<li>DigitalOcean Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/docn#NYSE">DOCN</a>) shares fell 10.6% to $28.15 as the company initiated CEO search process. Yancey Spruill will continue to serve as CEO until a successor has been appointed.</li>
<li>Limbach Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lmb#NASDAQ">LMB</a>) fell 10.5% to $32.10.</li>
<li>Weibo Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wb#NASDAQ">WB</a>) declined 9.7% to $12.36. Benchmark downgraded Weibo from Buy to Hold.</li>
<li>Nordstrom, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/jwn#NYSE">JWN</a>) fell 9.5% to $15.22 following second-quarter results. Total company net sales declined 8.3% year over year.</li>
<li>JE Cleantech Holdings Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/jcse#NASDAQ">JCSE</a>) fell 8.5% to $0.3290 after jumping 38% on Wednesday.</li>
<li>TD Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/glg#NASDAQ">GLG</a>) fell 8.1% to $0.75 after jumping 22% on Thursday. TD Holdings entered into a $165 million procurement agency agreement.</li>
<li>Myomo, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/myo#NYSE">MYO</a>) fell 8% to $0.69 after the company reported a proposed public offering.</li>
<li>Marvell Technology, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mrvl#NASDAQ">MRVL</a>) fell 6.4% to $53.60. Marvell Technology posted upbeat earnings for its second quarter. The company issued third-quarter 2024 revenue guidance of $1.4 billion plus or minus 5%, versus the $1.39 billion estimate.</li>
<li>Advance Auto Parts, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/aap#NYSE">AAP</a>) fell 6.3% to $63.63. Stephens &amp; Co. maintained Advance Auto Parts with an Equal-Weight and lowered the price target from $77 to $71.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/markets/cryptocurrency/23/08/34042277/bitcoin-ethereum-move-lower-pepe-becomes-top-loser"> Bitcoin, Ethereum Move Lower; Pepe Becomes Top Loser</a>

ACAX

AFRM

ALLG

AMSWA

BETR

BNOX

BRSH

CRKN

DOCN

DOMO

ELIQ

HIBB

IDEX

JCSE

LDWY

MRVL

NMRD

PGEN

PNAC

RCRT

RIBT

UTRS

VINO

Why Nordstrom Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session

<h3>Gainers</h3>
<ul>
<li>Tivic Health Systems, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tivc#NASDAQ">TIVC</a>) shares jumped 105% to $0.2050 after the company signed a distribution agreement with Cardinal Health.</li>
<li>Black Diamond Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bdtx#NASDAQ">BDTX</a>) surged 76.3% to $3.2450 after the company announced initial dose escalation data demonstrated anti-tumor activity of BDTX-1535 in non-small cell lung cancer patients across multiple EGFR mutation families.</li>
<li>Centogene N.V. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cntg#NASDAQ">CNTG</a>) rose 49% to $1.1675 after the company and Lifera formed a Saudi Arabian joint venture. Under the terms of the collaboration, the company will receive a $30 million mandatory convertible loan from Lifera.</li>
<li>CalciMedica, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/calc#NASDAQ">CALC</a>) climbed 37% to $4.43.</li>
<li>Cara Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cara#NASDAQ">CARA</a>) gained 22.1% to $3.9547. Cara Therapeutics was granted U.S. Patent #11684674: Oral formulations of kappa opioid receptor agonists.</li>
<li>AC Immune SA (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aciu#NASDAQ">ACIU</a>) rose 19.2% to $2.36 after the company received FDA fast track designation for anti-amyloid-beta active immunotherapy, ACI-24.060 for Alzheimer&#39;s disease.</li>
<li>American Equity Investment Life Holding Company (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ael#NYSE">AEL</a>) shares gained 17.6% to $53.02 after the company announced it has received a $55 per share acquisition proposal from Brookfield Reinsurance.</li>
<li>American Rebel Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/areb#NASDAQ">AREB</a>) jumped 16.6% to $5.47.</li>
<li>Biodexa Pharmaceuticals Plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bdrx#NASDAQ">BDRX</a>) rose 16.6% to $0.0729.</li>
<li>IronNet, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/irnt#NYSE">IRNT</a>) gained 14.8% to $0.2067 after dropping 13% on Monday.</li>
<li>Astrotech Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/astc#NASDAQ">ASTC</a>) gained 13.5% to $12.95. Astrotech 13D filing showed BML Investment Partners, L.P. increased stake in the company to 13%.</li>
<li>Aterian, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ater#NASDAQ">ATER</a>) rose 13% to $0.4099.</li>
<li>Enovix Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/envx#NASDAQ">ENVX</a>) gained 12.1% to $14.71 after the company announced it received a purchase order to produce battery cells for the U.S. Army.</li>
<li>WeWork Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/we#NYSE">WE</a>) rose 11.1% to $0.2601.</li>
<li>Moolec Science SA (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mlec#NASDAQ">MLEC</a>) gained 10.7% to $4.1817.</li>
<li>Edgewise Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ewtx#NASDAQ">EWTX</a>) rose 9.9% to $7.54 as the company released 12-month topline results from the ARCH study, an open-label, single-center study assessing EDG-5506 in adults with Becker Muscular Dystrophy (BMD).</li>
<li>NextPlay Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nxtp#NASDAQ">NXTP</a>) surged 9.7% to $1.13.</li>
<li>Ispire Technology Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ispr#NASDAQ">ISPR</a>) rose 9.6% to $8.52 after the company announced it raised roughly $8 million in a private placement of common stock.</li>
<li>Unity Software Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/u#NYSE">U</a>) gained 9.2% to $40.10 after the company announced a new AI marketplace and Wells Fargo initiated coverage on the stock with an Overweight rating and $48 price target.</li>
<li>InnSuites Hospitality Trust (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/iht#NYSE">IHT</a>) shares rose 8.8% to $2.84 after gaining 13% on Monday.</li>
<li>BIOLASE, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/biol#NASDAQ">BIOL</a>) shares gained 8.3% to $0.0852. Biolase was recently notified by Nasdaq that the company did not meet the minimum closing bid price requirement of $1.00 for continued listing.</li>
<li>View, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/view#NASDAQ">VIEW</a>) shares climbed 8.2% to $0.13 after declining around 10% on Monday. View recently filed a new patent application titled &quot;Environmental Adjustment Using Artificial Intelligence.&quot;</li>
<li>OneConnect Financial Technology Co., Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ocft#NASDAQ">OCFT</a>) shares gained 7.4% to $2.9650 after dropping 33% on Monday. The company recently reported first-quarter sales of $135.33 million, missing the consensus estimate of $143.91 million.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>Adicet Bio, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/acet#NASDAQ">ACET</a>) dropped 53.2% to $2.18 after the company shared safety and efficacy data from its Phase 1 study of ADI-001 for relapsed or refractory aggressive B-cell non-Hodgkin&#39;s lymphoma (NHL). JMP Securities downgraded Adicet Bio to Market Perform from Market Outperform rating.</li>
<li>Siyata Mobile Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/syta#NASDAQ">SYTA</a>) dipped 40% to $0.0533 after the company priced a 50 million share offering at $0.045 per share.</li>
<li>Lordstown Motors Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ride#NASDAQ">RIDE</a>) shares fell 31.3% to $1.90 after the company opted to file for Chapter 11 bankruptcy protection.</li>
<li>Xponential Fitness, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/xpof#NYSE">XPOF</a>) fell 30.2% to $17.52. Fuzzy Panda Research issued a short report titled &#39;Xponential Fitness (XPOF) &ndash; &quot;Abusive Franchisor That Is A House Of Cards.&quot;&#39;</li>
<li>Nkarta, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nktx#NASDAQ">NKTX</a>) dropped 26.6% to $3.3250 after the company released updated data from its Phase 1 study of NKX101 for relapsed or refractory acute myeloid leukemia.</li>
<li>Yellow Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/yell#NASDAQ">YELL</a>) declined 24.6% to $0.9573. Yellow filed $137M+ lawsuit against the International Brotherhood of Teamsters, alleging breach of contract in blocking efforts to modernize century-old company.</li>
<li>Bruush Oral Care Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/brsh#NASDAQ">BRSH</a>) fell 22.9% to $0.2575 after gaining around 10% on Monday.</li>
<li>Digital Media Solutions, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/dms#NYSE">DMS</a>) fell 21.1% to $0.3215 after jumping around 22% on Monday.</li>
<li>Terns Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tern#NASDAQ">TERN</a>) dropped 17.4% to $7.94. Terns Pharmaceuticals highlighted new preclinical data for TERN-601 program in obesity at the ADA&#39;s 83rd Annual Scientific Session and upcoming events.</li>
<li>Benitec Biopharma Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bntc#NASDAQ">BNTC</a>) fell 16.3% to $0.3012.</li>
<li>GSR II Meteora Acquisition Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gsrm#NASDAQ">GSRM</a>) fell 15.8% to $4.1099.</li>
<li>Viking Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vktx#NASDAQ">VKTX</a>) fell 15.7% to $15.29. Truist Securities reiterated Viking Therapeutics with a Buy and maintained a $32 price target.</li>
<li>NovaBay Pharmaceuticals, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nby#NYSE">NBY</a>) dipped 15% to $0.7438.</li>
<li>ReShape Lifesciences Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rsls#NASDAQ">RSLS</a>) fell 14.1% to $1.52. ReShape Lifesciences submitted FDA PMA supplement application for the next-generation Lap-Band 2.0.</li>
<li>iMedia Brands, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/imbi#NASDAQ">IMBI</a>) shares dropped 13.6% to $0.1641 after jumping 35% on Monday. iMedia Brands recently announced receipt of second Nasdaq non-compliance notice.</li>
<li>Akumin Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aku#NASDAQ">AKU</a>) fell 12.2% to $0.2190.</li>
<li>Madrigal Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mdgl#NASDAQ">MDGL</a>) dropped 11.9% to $207.31. Madrigal Pharmaceuticals recently presented Phase 3 MAESTRO-NASH data at the European Association for the Study of the Liver Congress.</li>
<li>Spark Networks SE (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lov#NASDAQ">LOV</a>) fell 9.5% to $0.3801 after jumping 50% on Monday. Spark Networks recently received notice from Nasdaq advising it has determined to deny the company&#39;s request for continued listing.</li>
<li>TMC the metals company Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tmc#NASDAQ">TMC</a>) declined 9.4% to $1.25.</li>
<li>Applied Digital Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/apld#NASDAQ">APLD</a>) shares dropped 9.3% to $8.34. Applied Digital sees Q4 revenue of $22 million and net loss of $6.8 million.</li>
<li>Walgreens Boots Alliance, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wba#NASDAQ">WBA</a>) dipped 9.2% to $28.70 after the company lowered its FY23 guidance.</li>
<li>Evelo Biosciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/evlo#NASDAQ">EVLO</a>) shares fell 9% to $0.1820 after gaining around 18% on Monday. Evelo Biosciences recently won U.S. Patent for prebiotic compositions and methods of use thereof for modulation of the microbiome.</li>
<li>Acelyrin, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/slrn#NASDAQ">SLRN</a>) dropped 8.3% to $21.92.</li>
<li>Super Group (SGHC) Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/sghc#NYSE">SGHC</a>) fell 7% to $2.82.</li>
<li>TD SYNNEX Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/snx#NYSE">SNX</a>) declined 7% to $90.89 after the company reported worse-than-expected second-quarter financial results and issued third-quarter adjusted EPS and revenue guidance below estimates.</li>
<li>CureVac N.V. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cvac#NASDAQ">CVAC</a>) dropped 6% to $10.91. CureVac recently dosed the first patient in its Phase 1 study of its cancer vaccine candidate for surgically resected glioblastoma.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/markets/cryptocurrency/23/06/33024579/bitcoin-rises-but-remains-below-this-key-level-bitcoin-cash-compound-among-top-gainers"> Bitcoin Rises But Remains Below This Key Level; Bitcoin Cash, Compound Among Top Gainers</a>

ACET

ACIU

APLD

ASTC

ATER

BDRX

BDTX

BIOL

BNTC

CARA

CNTG

CVAC

ENVX

EVLO

GSRM

IMBI

IRNT

ISPR

MDGL

Why Walgreens Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Top Stock Ideas Sent Daily — Join and Gain Your Edge

Top Stock Ideas Sent Daily — Join and Gain Your Edge

Comments

InnSuites Hospitality

InnSuites Hospitality (IHT) Forecast

InnSuites Hospitality (AMEX:IHT) Stock, Quote.Headers.trade-ideas